Immunization against endogenous retroviral tumor-associated antigens.
about
P1343
Melanoma, Darwinian medicine and the inner worldEndogenous retroviruses and the development of cancerBroad and potent neutralization of HIV-1 by a gp41-specific human antibodyRoles of lymphatic endothelial cells expressing peripheral tissue antigens in CD4 T-cell tolerance inductionAge-dependent tolerance to an endogenous tumor-associated antigen.CD40-activated B cells can efficiently prime antigen-specific naïve CD8+ T cells to generate effector but not memory T cells.Human endogenous retroviruses and cancer prevention: evidence and prospectsThe biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies.Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma.Isolation of human monoclonal antibodies from peripheral blood B cells.Dichotomy between T Cell and B Cell Tolerance to Neonatal Retroviral Infection Permits T Cell Therapy.Listeria-based cancer vaccines that segregate immunogenicity from toxicityFusion proteins of Hsp70 with tumor-associated antigen acting as a potent tumor vaccine and the C-terminal peptide-binding domain of Hsp70 being essential in inducing antigen-independent anti-tumor response in vivo.Multiple sclerosis: are protective immune mechanisms compromised by a complex infectious background?Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain.HERV Envelope Proteins: Physiological Role and Pathogenic Potential in Cancer and Autoimmunity.
P2860
Q24627770-566BF680-218D-4A8C-8496-CDA65B56FEDDQ26852000-BC6A8C64-5E9E-4C5D-8690-CBE72D2F432EQ27675131-225F5E23-84CF-4271-8D78-BC3E41923514Q30300213-AD6FA76A-3839-475B-9B07-C46B992D3016Q30439993-3159BDE9-7557-4A30-AA18-96866D67D7E0Q34145881-5BD9259D-C70B-4993-B19C-9FC84A61CE46Q34530623-623CBAE5-8837-4311-BFAC-86DD42F50971Q35226092-5D0FB1D6-9A01-465F-88B2-50DAABE561A7Q36004284-436013B0-9BEB-4B36-9FA9-17BCC23FD923Q36833296-F06119E5-4C2D-44B6-8AAC-1AD5530F3BFFQ37355615-D2B6CE40-948D-4CFB-835F-18269B9C652DQ37535306-A431139D-DACD-4753-8140-9E6EA45EC184Q40226012-B4648C8B-ABDC-4067-BA55-BC7E0822C1C4Q41486516-658FFA74-399C-416B-AC5C-6D7D9EBDB650Q45854947-1B1CD691-1FBD-4BFF-8822-4410E9F4B54AQ52338720-AE058B14-E697-4522-821E-3AF69A2845B2
P2860
Immunization against endogenous retroviral tumor-associated antigens.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Immunization against endogenous retroviral tumor-associated antigens.
@ast
Immunization against endogenous retroviral tumor-associated antigens.
@en
type
label
Immunization against endogenous retroviral tumor-associated antigens.
@ast
Immunization against endogenous retroviral tumor-associated antigens.
@en
prefLabel
Immunization against endogenous retroviral tumor-associated antigens.
@ast
Immunization against endogenous retroviral tumor-associated antigens.
@en
P2093
P2860
P1433
P1476
Immunization against endogenous retroviral tumor-associated antigens
@en
P2093
L L Parker
N P Restifo
R Lapointe
W Mondesire
W W Overwijk
P2860
P304
P407
P4510
P577
2001-11-01T00:00:00Z